Welcome to China Surfactant Detergent & Cosmetics, Today is
China Surfactant Detergent & Cosmetics ›› 2018, Vol. 48 ›› Issue (6): 314-321.doi: 10.13218/j.cnki.csdc.2018.06.003
• Lecture of science and technology • Previous Articles Next Articles
PAN Yao1,2, ZHAO Hua1,2
Received:2018-05-23
Published:2019-03-18
CLC Number:
PAN Yao, ZHAO Hua. Efficacy evaluation of cosmetics (Ⅵ) Experimental design of cosmetics human efficacy evaluation[J].China Surfactant Detergent & Cosmetics, 2018, 48(6): 314-321.
| [1] European Commission.Commission regulation (EU) No 655/2013 laying down common criteria for the justification of claims used in relation to cosmetic products [J].Official Journal of the European Union,2013,L190:31-34. [2] National Institutes for Food and Drug Control.Notice on publicly soliciting the “Guidelines for the evaluation of cosmetic efficacy claims” [EB/OL].(2018-01-24) [2018-05-21].http://www.nicpbp.org.cn/CL0901/10514.html. [3] Liu Wen-qing.Design of experiments [M].Beijing:Tsinghua University Press,2005. [4] Yang Jun-ying,Zhang Gui-qin.Experimental design scheme and selection of statistical analysis methods [J].Chinese Journal of Physical Medicine and Rehabilitation,2001(6):57-60. [5] Moher D,Hopewell S,Schulz K F,et al.Consort 2010 explanation and elaboration:updated guidelines for reporting parallel group randomised trials [J].BMJ,2010,340:869. [6] Li Jing.Clinical trial design:randomized controls [J].China Circulation Journal,2017(11):1126-1127. [7] Hu Wan,Sun Yan-song,Hu Liang-ping.How to follow the four principles of experimental design in physiological research [J].Chinese Journal of Applied Physiology,2017(1):89-93. [8] Fang Ji-qian.Statistical methods for biomedical research [M].Beijing:Higher Education Press,2007. [9] Li Li-ming,Ye Dong-qing,Zhan Si-yan.Epidemiology [M].Beijing:People's Medical Publishing House,2008. [10] Wang Qi,Hu Liang-ping.The concept and foundation of experimental design [J].Pharmaceutical Care and Research,2010(1):5-9. [11] Tang Long-mei,Yan Li-na,Wang Li-qin.Commonly used experimental design methods in medical research [J].Clinical Meta,2013(2):120-177. [12] Li Zi-an,Sun Chang-lei,Zhu Li-ping.Clinical efficacy test and analysis of ginseng anti-aging products [J].Chemicals for Daily Use,2015(12):48-51. [13] Ma Yan-feng,Bai Xiao-yun,Bao Jing-lin,et al.Comparative study on moisturizing effects of 2 face masks [J].Guangdong Chemical Industry,2013(17):77-78. [14] Jia Li-li,Li Yuan-hong,Wu Yan,et al.Clinical observation on white-ning effect and safety of resveratrol [J].Chinese Beauty Medicine,2012(9):1340-1342. [15] Xie Wen-jian,Jia Fang,Lv Ying,et al.Study on the evaluation of human effectiveness of four moisturizing skin care products [J].Spice Flavor Cosmetics,2015(2):40-42. [16] Ma Yan-feng,Bai Xiao-yun,Niu Wen-xia,et al.A preliminary study on the instant efficacy of a moisturizing facial mask [J].Spice Flavor Cosmetics,2014(5):38-40. [17] Chan A W,Tetzlaff J M,Gotzsche P C,et al.SPIRIT 2013 explanation and elaboration:guidance for protocols of clinical trials [J].BMJ,2013,346:7586. [18] Fey M F.Clinical trial design in oncology:selection of patients [J].Lancet Oncol,2004,5(12):760. [19] Zhang Qiang,Meng Ping,Shan Ai-lian.Some thoughts on the inclusion and exclusion criteria in drug clinical trial schemes [J].Chinese Journal of Clinical Pharmacology,2017(2):99-101. [20] Gui Yu-liang,Chen Zun,Tian Guo-xiang,et al.Reflections on the design of clinical trial schemes for clinical research design schemes [J].Chinese Journal of Evidence-Based Cardiovascular Medicine,2017(6):641-643. [21] State Food and Drug Administration.Cosmetic safety technical specification (2015 Edition) [Z].Beijing:2015. [22] Li Yun,Sun Qiu-ning,Yang Rong-ya,et al.Therapeutic effect observation of 862 patients with facial sensitive skin treated with soothing special cream [J].Practical Journal of Dermatology,2015(2):85-88. [23] Jiang Xian,Ji Ran,Lu Hua,et al.A randomized controlled study of the effects of Liquan Spring Soothing Spray on the adjuvant therapy of recurrent dermatitis in female faces [J].Journal of Sichuan University (Medical Science Edition),2008(2):343-344. [24] Rothman K J.Epidemiology.An introduction [M].Oxford:Oxford University Press,2012. [25] Wan Jin-jin,Liu Rui-xue,Leng Qun-ying.Study on the efficacy of a sensitive skin cream [J].Chemicals for Daily Use,2017(11):24-28. [26] Ye Cong-xiu,Lai Wei,Yi Jin-ling,et al.Study on evaluation method of lip moisturizing effectiveness of lip cosmetics [J].Chinese Beauty Medicine,2010(1):75-77. [27] Xia Xue,Guo Yi-rong,Chen Xue,et al.Research on the body effect of a new multi-effect cushion powder cream [J].Chemicals for Daily Use,2017(1):36-40. [28] Shen Ning,Hu Liang-ping.How to strictly abide by the principle of four principles of experimental design in mental health research [J].Sichuan Mental Health,2016(4):295-302. [29] Xie Xiao-yuan,Wang Ran,Lai Wei,et al.Discussion on the evaluation method of antidandruff cosmetic effect [J].Chinese Beauty Medicine,2010(1):72-74. [30] Gebski V.Clinical trial design in oncology:assessment of outcomes [J].Lancet Oncol,2004,5(12):761-763. [31] Wang Chun-xiao,Zhao Hua.Evaluation of cosmetic effectiveness (Ⅱ):scientific support for moisturizing effectiveness [J].Daily Chemical Industry,2018(2):67-72. [32] Zhao Hua,Wang Nan.Evaluation of cosmetic effectiveness (Ⅲ):scientific support for whitening effects [J].Daily Chemical Industry,2018(3):129-133. [33] Li Cheng-tong,Zhao Hua.Evaluation of cosmetic effectiveness (Ⅳ):scientific support for delaying skin aging [J].Daily Chemical Industry,2018(4):188-195. [34] Schulz K F,Grimes D A.Sample size calculations in randomised trials:mandatory and mystical [J].Lancet,2005,365(9467):1348-1353. [35] Han Mei,Yang Guo-yan,Wang Yu-yi,et al.Chinese medicine clinical trial scheme design ideas and report specification [J].Chinese Journal of Integrated Traditional Chinese and Western Medicine,2014(8):907-910. [36] World Medical Association Declaration of Helsinki.Recommendations guiding physicians in biomedical research involving human subjects [J].JAMA,1997,277(11):925-926. [37] Wang Xiao-xia,Li Yu-min.Grasp the clinical research plan to do a new drug clinical trial [J].Chinese Medicine and Clinical,2012(1):48-49. [38] Ambrosius W T.Topics in biostatistics [M].New Jersey:Humana Press,2007. [39] Wu Yan,Zhong Shao-min,Joe Kaczvinsky,et al.Effect of nicotinamide and N-acetylglucosamine on pigmentation [J].Clinical Journal of Dermatology,2007(10):628-631. [40] Brocklehurst P,Hoare Z.How to design a randomised controlled trial [J].Br Dent J,2017,222(9):721-726. [41] Hou Wei,Zhang Jie-chen,Tian Wei-wei,et al.Randomized,double-blind,self-controlled study on chloasma cream in the treatment of chloasma [J].Chinese Beauty Medicine,2011(5):792-795. [42] Bigby M,Gadenne A S.Understanding and evaluating clinical trials [J].J Am Acad Dermatol,1996,34(4):555-590,591-593. [43] Alosh M,Fritsch K,Soukup M,et al.Clinical trials and statistical analyses:what should dermatologists look for in a report ? [J].Dermatol Ther,2009,22(3):199-203. [44] Calvert M,Kyte D,Mercieca-bebber R,et al.Guidelines for inclusion of patient-reported outcomes in clinical trial protocols:the SPIRIT-PRO extension [J].JAMA,2018,319(5):483-494. [45] Kawashima M,Nagare T,Doi M.Clinical efficacy and safety of benzoyl peroxide for acne vulgaris:Comparison between Japanese and Western patients [J].J Dermatol,2017,44(11):1212-1218. [46] ICH.Guideline for good clinical practice E6 (R2) [EB/OL].(2016-11-09)[2018-05-21].http://www.ich.org/fileadmin/Public-Web-Site/ICH-Products/Guidelines/Efficacy/E6/E6_R2_Step_4_2016_1109.pdf. [47] China Food and Drug Administration.General office of the general administration of China publicly solicits opinions on the “Quality control regulations for drug clinical trials (revised draft)” [EB/OL].(2016-12-01)[2018-05-21].http://samr.cfda.gov.cn/WS01/CL0778/166981.html. [48] Grimes D A,Hubacher D,Nanda K,et al.The good clinical practice guideline:a bronze standard for clinical research [J].Lancet,2005,366(9480):172-174. [49] Sheng Xiao-yan,Xu Jun-yu,Liang Yan,et al.Formulation and management of standard operating procedures for phase I drug clinical trials [J].Chinese Journal of Clinical Pharmacology,2017(14):1357-1359. [50] Liu Huan,Yang Li.Analysis of influencing factors of clinical trial quality [J].Chinese Journal of New Drugs,2018(6):678-681. |
| [1] | Jingxuan Liu, Jianming Jin, Hua Wu. Botanical cosmetic ingredients （VII）Research and development of plant antifungal [J]. China Surfactant Detergent & Cosmetics, 2024, 54(3): 259-266. |
| [2] | Wu Bi, Xiaohong Pan, Xiaoqin Tu, Shuai Yin, Hui Sun. Analysis of the mechanism of anti-sensitive skin effect of cosmetic raw material Stephania tetrandra based on network pharmacology [J]. China Surfactant Detergent & Cosmetics, 2024, 54(3): 305-312. |
| [3] | Yaoyao Li. Study on the anti-aging and antioxidant effects of isosinensetin [J]. China Surfactant Detergent & Cosmetics, 2024, 54(3): 313-319. |
| [4] | Mengran Xu, Hua Zhao. Research progress on the evaluation methods of cosmetic after-sun repair efficacy [J]. China Surfactant Detergent & Cosmetics, 2024, 54(3): 329-336. |
| [5] | Liyuan Zhang, Linqi Yan, Qiaoyuan Cheng, Lvye Qi, Rong Wang, Liuqian Huang. Determination of 14 kinds of α-hydroxy acids and hydroxy esters in cosmetics [J]. China Surfactant Detergent & Cosmetics, 2024, 54(3): 353-359. |
| [6] | Wei Xu, Po Zou, Changyu Li, Ming Yang, Yan Lu, Huiliang Li. Determination of 36 stimulants in cosmetics by ultra performance liquid chromatography-tandem mass spectrometry [J]. China Surfactant Detergent & Cosmetics, 2024, 54(3): 360-368. |
| [7] | Kangfu Zhou, Yixuan Zhi, Feifei Wang, Yazhuo Shang. New emulsion system and its application in cosmetics （VI）Microemulsion [J]. China Surfactant Detergent & Cosmetics, 2024, 54(2): 139-148. |
| [8] | Zhen Xie, Wei Huang, Jinsong Zhang, Shuhuai Chen, Linji Qu, Rong Kuang. Study on biomarkers of corneal injury in the evaluation of eye irritation of cosmetics [J]. China Surfactant Detergent & Cosmetics, 2024, 54(2): 161-167. |
| [9] | Huiyi Li, Yue Zhou, Qian Wu, Lidi Du, Jiaying Xie, Jianhua Tan. Evaluation of cosmetics in melanin inhibition efficacy [J]. China Surfactant Detergent & Cosmetics, 2024, 54(2): 168-174. |
| [10] | Xiaohong Pan, Ziqi Gao, Zhen Chen, Shuai Yin, Haiping Huang, Bin Hu. Discussion on the current situation of research and management on the stability of cosmetic products in China [J]. China Surfactant Detergent & Cosmetics, 2024, 54(2): 201-208. |
| [11] | Li Lu, Fang Fang, Youlong Feng, Ling Cao. Screening for illegal addition of sulfonamides in cosmetic products using ultra-performance liquid chromatographytriple quadrupoletandem mass spectrometry with precursor ion scanning [J]. China Surfactant Detergent & Cosmetics, 2024, 54(2): 216-223. |
| [12] | Ren Wang, Yuanyang Wu, Jia Qiao, Linqi Yan, Cen Chen, Liyuan Zhang. Study on phenoxyethanol content in children’s cosmetics on the mark and preliminary risk assessment [J]. China Surfactant Detergent & Cosmetics, 2024, 54(2): 224-230. |
| [13] | Yixiang Lu, Liting Wu, Jimin Jiang, Hailu Chen, Xuan Huang. Determination of tolnaftate and liranaftate in cosmetics by high performance liquid chromatography and verification by high performance liquid chromatography-tandem mass spectrometry [J]. China Surfactant Detergent & Cosmetics, 2024, 54(2): 231-238. |
| [14] | Liyuan Zhang, Qiaoyuan Cheng, Cen Chen, Zehua Li, Liuqian Huang, Lvye Qi. Determination of 3 kinds of α-hydroxy acids and their esters in cosmetics by high performance liquid chromatography [J]. China Surfactant Detergent & Cosmetics, 2024, 54(1): 102-106. |
| [15] | Linling Lu, Hui Lu, Chunyan Min, Yefei Qian. Determination of functional components of Glycyrrhizae, Ginseng and Scutellariae in facial masks by UHPLC-MS/MS [J]. China Surfactant Detergent & Cosmetics, 2024, 54(1): 107-113. |
|
